A clinical study on Meganathi kuligai for UthiraVatha suronitham(Rheumatoid Arthritis)
Phase 2
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2020/03/024153
- Lead Sponsor
- Government siddha medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Symmetrical joint involvement
2.Involvement of 3 or more joints
3.Florid morning stiffness and swelling that lasts for few hours or days
4.pain,joint swelling especially in the interphalangeal joints
5.pain criteria score should be greater than or equal to 6.
Exclusion Criteria
1.Psoriatic arthritis
2.Gout
3.Mixed connective tissue disorders
4.SLE
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Reducing the pain, swelling, early morning stiffness,deformities. <br/ ><br>2.To assess improvement based on the disease activity pain score.Timepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method 1.Evaluation of addition effects and siddha parameters during trial period. <br/ ><br>2. Determination of safety profile of trial drug . <br/ ><br>3. Evaluation of Bio Chemical investigation parameters.Timepoint: 45 days